September 2026

A Look at Implants for Diabetic Eye Disease

A review of approved and emerging implant-based treatments for diabetic retinopathy and diabetic macular edema.

Matthew Pfannenstiel, MD, and Leanne M. Clevenger, MD

The Potential of Tyrosine Kinase Inhibitors

This novel class of drug may one day help to address the growing burden of diabetic eye disease.

Shawn Kavoussi, MD

What Pathogen Type Reveals About Endophthalmitis

Certain types of bacteria may be linked to a more aggressive disease course post-procedure.

Saagar Patel, MD; Christopher Conrady, MD, PhD; and Talisa E. De Carlo Forest, MD

ARDS 2026: Expert Perspectives

Three panels tackled tough surgical and medical topics.

Caroline C. Awh, MD

AI in DME: From Promise to Clinical Practice

New data show the growing utility of AI-assisted screening, referrals, and treatment response prediction.

Scott Song, BA, and T. Y. Alvin Liu, MD

Optimizing Functional Outcomes in PVR

Practical strategies and decision making for proliferative vitreoretinopathy surgery.

Neil Shah, MBBS, FRCOphth, and Rodrigo Anguita, MBBS, MD, FEBO, FICO

Global DR Screening: Why Aren’t We There Yet?

A look at the hope and hurdles of global screening implementation.

Majda Hadziahmetovic, MD; Michael D. Abramoff, MD, PhD; Abdullah AlQahtani, MD, DES, DISSO, FEBO; Gavin Tan Siew Wei, MBBS, PhD; Sobha Sivaprasad, MBBS, MS, DM, FRCS, FRCOphth; Lloyd Harrison-Williams, MD; and Jorge C. P. Rocha, MD, PhD